The Smart Investor
    Facebook Instagram
    Thursday, July 16
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»3 Defensive Stocks to Protect Your Portfolio in 2026
    Dividend Stocks

    3 Defensive Stocks to Protect Your Portfolio in 2026

    These three defensive Singapore stocks could help investors protect income and stability as markets stay volatile heading into 2026.
    Daniel L.By Daniel L.January 7, 2026Updated:January 8, 20266 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Raffles medical
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Why Defence Matters in 2026

    The global outlook for 2026 remains uncertain despite lower inflation expectations and impending rate cuts by central banks.

    Geopolitical tensions, uneven global economic growth and shifting interest-rate expectations are the key factors driving market volatility.

    Given these uncertainties, investors should look towards defensive stocks to help cushion their portfolios with stable earnings and dependable cash flow.

    In this article, we look at three defensive Singapore stocks that stand out: Singtel, Sheng Siong and Raffles Medical Group.

    Singapore Telecommunications (SGX: Z74, SingTel) – Asia’s Leading Communications Technology Group

    Singtel is a leading communications technology group and has a wide presence across Asia, Australia and Africa, with mobile subscribers of over 800 million in 20 countries. 

    Given Singtel’s telecom business being widely regarded as an essential service and the extensive business operations across different regions, the company is considered a defensive counter in the eyes of investors.

    With management’s ongoing efforts to unlock value and asset recycling initiatives, investors can rest assured that future dividends payout is sustainable in the long run.

    In its latest half year results ended 30 September 2025 (1HFY2025), Singtel’s operating revenue was down 1.2% year on year (YoY) to S$6.91 billion due to the strong Singapore dollar, given that a large part of Singtel’s revenue is generated from overseas operations.

    Despite the decline, Singtel’s underlying net profit was up 14% YoY to S$1.35 billion, driven mainly by regional associates Airtel and AIS, and operating companies NCS and Optus.

    On the capital management front, Singtel’s net debt was down to S$8.7 billion, mainly from the divestment of a 1.2% stake in Airtel.

    Cash balance stood at S$3.4 billion with close to 90% of its debts hedged at fixed rates and all foreign currency debt is hedged. 

    Meanwhile, Singtel generated S$3.7 billion worth of free cash flow, of which S$1.4 billion were from operating activities, plus capital recycling proceeds of S$2.3 billion.

    With better financial performance, Singtel increased its interim dividend by 17% YoY to S$0.082. 

    With the current share price of S$4.53, its trailing 12-month dividend yield is 4%.

    Looking ahead, Singtel will be looking to strengthen its core telecom operations in both Singapore and Australia.

    On the regional associates, Singtel foresees a brighter outlook given that Airtel has witnessed robust growth in home broadband & potential further pricing uplift and early signs of market recovery for Telkomsel.

    Sheng Siong Group (SGX: OV8) – Major Supermarket Chain in Singapore

    With 85 outlets across Singapore, Sheng Siong provides essential grocery services to consumers, which includes a wide range of live, fresh and chilled produce, and general merchandise such as toiletries and household products.

    Given the resilient nature of essential services and the various handouts and vouchers by the government over the past year, this has created stable consumer demand amidst risk of impending economic slowdown in 2026.

    With their heartland locations and competitive pricing, it makes Sheng Siong’s business model even more appealing to value-focused consumers here in Singapore.

    In the latest 3Q2025 result, Sheng Siong posted a revenue growth of 14.4% YoY to S$415.5 million, driven by higher store count growth.

    In addition, the higher comparable same store sales also helped to grow its topline in the same period.

    Sheng Siong has also done well in the margin segment, with gross profit margin improved by 0.2 percentage points to 31.5%, mainly due to improvement in sales mix while navigating rising business operation costs.

    As a result, the company’s net profit after tax rose 12.0% YoY to S$43.8 million for 3Q2025.

    Looking ahead, Sheng Siong expects the upcoming new distribution centre and headquarter at Sungei Kadut will help support the company’s continued expansion as the new facility can support the operations of 120 supermarkets.

    In terms of store count growth, Sheng Siong is on the lookout for viable retail space in Singapore’s housing estates and targets to open at least three stores per year.

    Raffles Medical Group (SGX: BSL) – Key integrated private healthcare provider in Asia

    Raffles Medical is one of the leading integrated private healthcare providers in the region, providing a wide range of services from primary and tertiary care to health insurance across Asia.

    The structural demand for healthcare, fueled by an aging population, positions Raffles Medical as a defensive play, making it less vulnerable to the anticipated economic downturn in 2026.

    In the first half of 2025 (1H2025), Raffles Medical reported a revenue growth of 3.5% YoY to S$378.4 million, driven by stronger contributions from both the hospital services and healthcare services divisions.

    Despite the losses from its China operations and insurance business, Raffles Medical’s profit after tax was up 5% YoY to S$32.5 million.

    On the cash flow front, Raffles Medical generated S$56.6 million in operating cash flow in 1H2025 and paid out a dividend amount totalling S$46.3 million in April 2025.

    With that, Raffles Medical revised its dividend policy in February 2025 to distribute at least 50% sustainable earnings annually and a share buy back program of up to 100 million shares over the next two years.

    These latest initiatives are supported by a strong balance sheet with S$334.2 million in cash and cash equivalents as of 30 June 2025. 

    Looking ahead, Raffles Medical expects the healthcare sector to remain a resilient, non-cyclical pillar of the economy, with performance underpinned by steady healthcare requirements and long-term structural growth drivers.

    Building a Defensive Portfolio the Smart Way

    In short, defence is not about steering clear away from growth, but managing investors’ downside risk.

    Some of these defensive traits revolve around essential services, consumer staples and healthcare services for balance.

    In the long run, defensive stocks can help to anchor an investor’s portfolio while allowing them to look towards selective growth exposure elsewhere.

    Get Smart: Defensive is not bad after all

    In times of uncertainties, capital preservation is the key priority as much as looking at sizable returns.

    Companies such as Singtel, Sheng Siong, and Raffles Medical offer stability, cash flow and resilience for investors.

    A well-defended portfolio gives investors staying power in the market for long-term compounding.

    If you want to retire with a constant stream of dividends, these 5 stocks might be all you need. We’ve found 5 SG stocks that have kept paying (and growing) through inflation, rate hikes, and recessions. See what they are with our latest free report for SGX dividend investors. Click here to get instant access.

    Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses!

    Disclosure: Daniel does not own shares in any of the companies mentioned.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Microsoft

    3 US Growth Stocks That Wall Street Is Ignoring

    July 15, 2026
    VISA

    Get Smart: The Invisible Moat You Don’t See

    July 15, 2026
    DBS

    Top 3 Temasek-Backed SGX Blue-Chip Stocks

    July 15, 2026
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.